Tamarack Advisers, LP Nuvasive Inc Transaction History

Tamarack Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$44.53 - $58.9 $22.3 Million - $29.5 Million	-500,000 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$47.64 - $71.26 $1.19 Million - $1.78 Million	-25,000 Reduced 4.76%	500,000 $24.8 Million
Q3 2018 Nov 13, 2018	BUY	$52.03 - $71.41 $1.3 Million - $1.79 Million	25,000 Added 5.0%	525,000 $37.4 Million
Q2 2018 Aug 14, 2018	BUY	$48.15 - $56.68 $6.74 Million - $7.94 Million	140,000 Added 38.89%	500,000 $26.1 Million
Q1 2018 May 08, 2018	BUY	$46.03 - $61.28 $6.89 Million - $9.17 Million	149,660 Added 71.15%	360,000 $18.8 Million
Q4 2017 Feb 14, 2018	BUY	$50.58 - $60.79 $2.55 Million - $3.06 Million	50,340 Added 31.46%	210,340 $12.3 Million
Q3 2017 Nov 13, 2017	BUY	$53.54 - $68.0 $8.57 Million - $10.9 Million	160,000	160,000 $8.87 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.